| AAV | Adeno-associated virus |
| Ab | Antibodies |
| AIR | Adaptative immune response |
| AOD | Apoptotic oligodendrocytes |
| AP | Apoptosis |
| BBB | Blood–brain barrier |
| Cas9 | CRISPR-associated protein 9 |
| CK | Cytokines |
| CNS | Central Nervous System |
| CRISPR | Clustered Regularly Interspaced Short Palindromic Repeats |
| DMDP | 2,5-dideoxy-2,5-imino-D-mannitol |
| DMSO | Dimethyl sulfoxide |
| DOAJ | Directory of open access journals |
| DSB | Double-strand break |
| ECC | Extracellular compartment |
| EE | Early endosome |
| ERT | Enzyme Replacement Therapy |
| FDA | Food and Drug Administration |
| GAG | Glycosaminoglycans |
| GCS | Glucosylceramide synthase |
| GluCer | Glucosylceramide |
| GM2-AP | GM2-activator protein |
| GT | Gene therapy |
| GVHD | Graft-versus-host disease |
| HDR | Homologous direct repair |
| Hex | Hexosaminidase |
| HLA | human leukocyte antigen |
| HSCT | Hematopoietic Stem Cell Transplantation |
| ICC | Intracellular compartment |
| IIR | Innate immune response |
| iPS | Induced pluripotent stem |
| LacCer | Lactoceramide |
| LD | Linear dichroism |
| LSD | Lysosomal Storage Disorders |
| M6PR | Mannose-6 phosphate receptor |
| MDPI | Multidisciplinary Digital Publishing Institute |
| MPS | Mucopolysaccharidosis |
| MUG | 4-methlyumbelliferyl-N-acetylglucosaminide |
| MUGS | 4-methylumbelliferyl-beta-D-N-acetyl-glucosamine-6-sulfate |
| NHEJ | Non-homologous end joining |
| OD | Oligodendrocytes |
| PC | Pharmacological Chaperones |
| PERK | PKR-like endoplasmic reticulum kinase |
| PGRN | Progranulin |
| PS | Phosphatidylserine |
| PYR | Pyrimethamine |
| RER | Rough endoplasmic reticulum |
| SD | Sandhoff disease |
| SRT | Substrate Reduction Therapy |
| TGN | Trans-Golgi network |
| TSD | Tay–Sachs disease |
| UCB | Umbilical cordon blood |